Lineage Cell Therapeutics, Inc.
LCTX
DELAYED 1 MONTH
4 insider filings · Latest: Mar 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Mar 12 8:05 PM | Brian M CulleyDirector, President and CEO | Purchase | 15,000 | $1.63 | $24.4K | 255,516(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Mar 7 12:51 AM | Brian M CulleyDirector, President and CEO | Grant/Award | 3,250,000 | $1.84 | 3,250,000(D) | View → |
| Mar 5, 2026 | Mar 7 12:50 AM | Jill Ann HoweChief Financial Officer | Grant/Award | 1,050,000 | $1.84 | 1,050,000(D) | View → |
| Mar 5, 2026 | Mar 7 12:48 AM | George A. Samuel IIIGeneral Counsel and Secretary | Grant/Award | 900,000 | $1.84 | 900,000(D) | View → |